Bionor Pharma ASA : Bionor Researchers to Present Data on Vacc-4x Phase IIB Trial at World Vaccine Congress, Washington, DC
04/12/2012| 12:57pm US/Eastern
Recommend:
0
Bionor Researchers to Present Data on Vacc-4x Phase IIB Trial
at World Vaccine Congress, Washington, DC
[Washington, DC -- 12 April 2012] Researchers from Bionor
Pharma have been invited to present data at the World Vaccine
Congress, on 13 April 2012.
Chief Scientific Officer Maja Sommerfelt will present
quality controlled data with more details on the findings
issued in 1Q 2012 indicating a statistically significant
drop in viral load for patients who were given therapeutic
HIV vaccine candidate Vacc-4x compared to those given a
placebo.
Recommend:
